| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $687K | +171.5% |
| SG&A Expense | $271K | -51.8% |
| Operating Income | -$958K | -17.5% |
| Pre-tax Income | -$1.0M | -74.3% |
| Net Income | -$680K | -109.9% |
| EPS (Basic) | -$0.16 | -100.0% |
| EPS (Diluted) | -$0.16 | -100.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $96K | -45.5% |
| Current Assets | $131K | -88.5% |
| Total Assets | $558K | -60.4% |
| Total Liabilities | $3.2M | +3.1% |
| Stockholders' Equity | -$2.9M | -27.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$488K | +47.6% |
| Capital Expenditures | $269K | +240.5% |
| Investing Cash Flow | $368K | +151.0% |
| Financing Cash Flow | $40K | -96.1% |
| Free Cash Flow | -$757K | +25.1% |